🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Kalifornija

Kliničke studije za Akutna mijeloidna leukemija u državi Kalifornija

79 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u državi Kalifornija.

Gradovi u državi Kalifornija

Zvanični tekst studije (na engleskom)

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

  • City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte
Тражи се учесникФаза 1
Узраст 65 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06552416

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • UCI Health Chao Family Comprehensive Cancer Center, Orange
  • University of California Davis Comprehensive Cancer Center, Sacramento
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07304011

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и још 17
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  • University of California, Fresno, Clovis
  • University of California, San Diego, La Jolla
  • Cedars-Sinai Medical Center, Los Angeles
  • и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

  • City of Hope, Duarte
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 12 до 120 · Оба пола · Ажурирано 10. 11. 2026. · NCT05436418

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

  • Cedars-Sinai Medical Center, Los Angeles
  • Kaiser Permanente-Oakland, Oakland
  • Kaiser Permanente-Roseville, Roseville
  • и још 3
Тражи се учесникФаза 2
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT06996119

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05672147

HPC Offered for PRESERVE Expansion

  • City of Hope, Duarte
Тражи се учесникОпсервациона студија
Узраст од 12 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07145411

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

  • US-Los Angeles CA-UCLA, Los Angeles
  • US-San Francisco CA-UCSF, San Francisco
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07223814

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  • City of Hope Center Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07751991

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
  • PCR Oncology, Arroyo Grande
  • AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
  • и још 22
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

  • City of Hope, Duarte
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06852222

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • и још 19
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

  • City of Hope Comprehensive Cancer Center - Duarte, Duarte
  • University of California Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст од 18 до 70 · Оба пола · Ажурирано 30. 10. 2026. · NCT06287944

Study of REM-422 in Patients With AML or Higher Risk MDS

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06297941

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  • City of Hope, Duarte
  • UCLA, Los Angeles
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

  • Cedars-Sinai Medical Center, Los Angeles
  • Kaiser Permanente-Oakland, Oakland
  • Kaiser Permanente-Roseville, Roseville
  • и још 2
Тражи се учесникФаза 2
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

  • UCSF Medical Center-Parnassus, San Francisco
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06672146

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06059391

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

  • City of Hope Comprehensive Cancer Center, Duarte
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06969430

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

  • UCSF Medical Center-Mission Bay, San Francisco
Тражи се учесникФаза 1
До 21 година · Оба пола · Ажурирано 23. 10. 2026. · NCT07012044

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT07020533

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

  • Rady Children's Hospital, San Diego
Тражи се учесникФаза 1
Узраст од 1 до 30 · Оба пола · Ажурирано 22. 10. 2026. · NCT06177067

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

  • City of Hope National Medical Center /ID# 279568, Duarte
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07581002

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

  • University of California, Davis Comprehensive Cancer Center, Sacramento
Тражи се учесникФаза 1
Узраст од 18 до 85 · Оба пола · Ажурирано 21. 10. 2026. · NCT06834282

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  • Clinical Trial Site, Duarte
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT07211958

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDS

  • City of Hope, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06533761

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06543381

A Study of Revumenib and Mezigdomide in People With Leukemia

  • City of Hope Cancer Center (Data collection only), Duarte
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 2 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06575296

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

  • City of Hope National Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06846606

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст од 2 до 22 · Оба пола · Ажурирано 14. 10. 2026. · NCT06128070

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

  • Stanford University, Palo Alto
Тражи се учесникФаза 1
Узраст од 2 до 30 · Оба пола · Ажурирано 14. 10. 2026. · NCT05188170

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07582172

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

  • Keck School of Medicine of USC, Los Angeles
  • UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

Individualized AML Treatment

  • City of Hope Medical Center, Duarte
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07613385

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

  • Lucile Packard Children's Hospital /ID# 276015, Palo Alto
Тражи се учесникФаза 1
6 Months – 17 Years · Оба пола · Ажурирано 5. 10. 2026. · NCT07306832

A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  • City of Hope Medical Center, Duarte
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 29. 9. 2026. · NCT06763341

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.